Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

BACKGROUND: Adult T-cell leukemia lymphoma (ATLL) is a chemotherapy-resistant malignancy with a median survival of less than one year that will afflict between one hundred thousand and one million individuals worldwide who are currently infected with human T-cell leukemia virus type 1. Recurrent som...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Retrovirology
Main Authors: Rauch, Daniel A., Olson, Sydney L., Harding, John C., Sundaramoorthi, Hemalatha, Kim, Youngsoo, Zhou, Tianyuan, MacLeod, A. Robert, Challen, Grant, Ratner, Lee
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456374/
https://ncbi.nlm.nih.gov/pubmed/32859220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-020-00535-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares